Fredun Pharmaceuticals has informed about the copies of the Newspaper cuttings of the Financials Results of the Company for the year ended March 31, 2018; as approved by the Board in its Meeting held on Monday, June 18, 2018; published in Free-press Journal & Navshakti on Wednesday, June 20, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1664.20 |
| Dr. Reddys Lab | 1215.95 |
| Cipla | 1227.95 |
| Zydus Lifesciences | 927.55 |
| Lupin | 2293.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: